BANK OF MONTREAL /CAN/ - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,414,000
-27.4%
69,978
+31.7%
0.00%0.0%
Q2 2021$1,948,000
-5.3%
53,125
-31.7%
0.00%0.0%
Q1 2021$2,057,000
-27.0%
77,828
-33.4%
0.00%
-50.0%
Q4 2020$2,816,000
+9.6%
116,833
-16.0%
0.00%0.0%
Q3 2020$2,570,000
-30.4%
139,028
-4.4%
0.00%
-33.3%
Q2 2020$3,692,000
+7.5%
145,395
-22.6%
0.00%
-25.0%
Q1 2020$3,436,000
+221.4%
187,757
+286.9%
0.00%
+300.0%
Q4 2019$1,069,000
+1544.6%
48,531
+968.7%
0.00%
Q3 2019$65,000
-4.4%
4,541
+5.7%
0.00%
Q2 2019$68,000
+750.0%
4,298
+465.5%
0.00%
Q4 2018$8,000
+60.0%
760
+142.0%
0.00%
Q3 2018$5,000
-99.4%
314
-99.6%
0.00%
-100.0%
Q2 2018$898,000
+1051.3%
73,316
+218.8%
0.00%
Q1 2017$78,000
-6.0%
23,000
-16.7%
0.00%
Q4 2016$83,000
-37.6%
27,609
+22.1%
0.00%
Q3 2016$133,000
+79.7%
22,609
-8.1%
0.00%
Q2 2016$74,000
+469.2%
24,609
+935.3%
0.00%
Q1 2016$13,000
+550.0%
2,377
+1144.5%
0.00%
Q4 2015$2,0000.0%191
+112.2%
0.00%
Q2 2014$2,000900.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders